Friday - March 14, 2025
Novo Holdings A/S, Bpifrance, Invus and UI Investissement Invest in the Euros32 Million Series A Financing of Coave Therapeutics
January 14, 2025
BOSTON, Massachusetts, Jan. 14 -- Goodwin, a law firm, issued the following news release:

Our Paris Technology team advised Novo Holdings A/S, Bpifrance, Invus and UI Investissement on their investment in the Euros32 million Series A financing of Coave Therapeutics, a company pioneering the future of genetic medicines.

The round was co-led by Novo Holdings A/S and Bpifrance, with participation from Invus and UI Investissement, alongside existing investors Seroba Life Sc . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products